Beijing, China

Haiqing Hua

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Beijing Tuo Jie Biopharmaceutical Co. Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haiqing Hua. Retrieved from https://idiyas.com/inventor/haiqing-hua-i8l5ems5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Haiqing Hua

Introduction

Haiqing Hua is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biopharmaceuticals. His work focuses on developing innovative compounds that can have a substantial impact on medical treatments.

Latest Patents

Haiqing Hua holds a patent for a "Dual-agonist compound for both GLP-1 and GIP receptors and application thereof." This patent showcases his expertise in creating compounds that target specific receptors, which can lead to advancements in therapeutic options.

Career Highlights

Hua is currently employed at Beijing Tuo Jie Biopharmaceutical Co. Ltd. His role at the company allows him to engage in cutting-edge research and development. His contributions have been instrumental in the progress of biopharmaceutical innovations.

Collaborations

Some of his notable coworkers include Fangzhou Wu and Lei Wang. Their collaboration fosters a dynamic environment for innovation and research within the company.

Conclusion

Haiqing Hua's work exemplifies the spirit of innovation in the biopharmaceutical industry. His patent and career achievements highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…